News
Scotiabank analyst Ovais Habib raised the firm’s price target on Orla Mining (ORLA) to C$16 from C$15.50 and keeps an Outperform rating on the shares. Scotia noted that Orla reported its first ...
Of the 22 guru strategies we follow, HES rates highest using our Acquirer's Multiple Investor model based on the published strategy of Tobias Carlisle. This deep value model looks for inexpensive ...
BofA analyst Brad Sills lowered the firm’s price target on DocuSign (DOCU) to $85 from $88 and keeps a Neutral rating on the shares, calling Q1 results “somewhat disappointing.” The magnitude of the ...
Criminals exploit the trust teens have in iPhone messaging, and use the platform to make relentless demands for money. Continue Reading View comments ...
Google are increasing as the U.S. Department of Justice’s search antitrust case nears a decision, with remedies ...
CVRx, Inc. (NASDAQ:CVRX), operating within the medical device sector, has experienced a notable change in short interest ...
Provident Bancorp Inc (NASDAQ:PVBC) experienced a notable change in short interest during May, reflecting evolving trading ...
AbbVie Inc., (NYSE:ABBV) a leading healthcare entity listed on S&P 500 Chart index, recently saw a shift in institutional ...
Stepan, a company operating in the basic materials sector and listed on the NYSE under ticker (NYSE:SCL), is also included in ...
Nektar Therapeutics (NASDAQ:NKTR), a biopharmaceutical company operating in the Top 10 Nasdaq Stocks biotechnology sector.
NeuroSense Therapeutics, (NASDAQ:NRSN) operating under the Top Nasdaq Companies by Market Cap index, is part of the ...
Imunon, Inc. (NASDAQ:IMNN), a company operating in the biotechnology sector, is part of key market indexes such as the Top ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results